Antioxidants and dipyridamole inhibit HIV-1 gp120-induced free radical-based oxidative damage to human monocytoid cells

Irene O. Foga, Avindra Nath, Brian B. Hasinoff, Jonathan D. Geiger

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Reactive oxygen species (ROS) may play an important role in HIV-1 pathogenesis and HIV-1 gp120-induced neurotoxicity. Our studies determined the extent to which gp120 increased ROS production in human monocytic U937 cells and the effectiveness of various agents, including dipyridamole (DPR), in blocking these responses. The thiobarbituric acid-reactive substances (TBARS) assay was used as a measure of recombinant gp120 (HIV-13B)-induced oxidative damage to U937 cells. As a control, TBARS production was measured using a hypoxanthine/xanthine superoxide generating system. There was gp120-induced oxidative damage in U937 cells with a concentration that produces 50% of maximal effect (apparent EC50 value) of 11 pM. Polyclonal antiserum to gp120 significantly (p < 0.05) inhibited gp120-induced oxidative damage. gp120-induced oxidative damage was significantly inhibited 81% (p < 0.01) by catalase/superoxide dismutase, 53% (p < 0.05) by (±)-α-tocopherol, 78% (p < 0.01) by desferrioxamine, and 82% (p < 0.01) by ethylene diamine tetraacetic acid (EDTA). These results indicate that gp120 is capable of promoting iron-based oxygen free radical damage to U937 cells. DPR potently (p < 0.05) inhibited both hypoxanthine/xanthine- and gp120-induced oxidative damage with concentrations that produce 50% inhibition (apparent IC50 values) of 1.3 μM for hypoxanthine/xanthine and 1.0 μM for gp120. Therapeutic intervention against ROS production may prevent HIV-1 neurotoxicity.

Original languageEnglish (US)
Pages (from-to)223-229
Number of pages7
JournalJournal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Volume16
Issue number4
DOIs
StatePublished - Dec 1 1997

Fingerprint

U937 Cells
Dipyridamole
Hypoxanthine
Free Radicals
Xanthine
HIV-1
Reactive Oxygen Species
Antioxidants
Thiobarbituric Acid Reactive Substances
HIV Envelope Protein gp120
Deferoxamine
Diamines
Tocopherols
Superoxides
Catalase
Inhibitory Concentration 50
Superoxide Dismutase
Immune Sera
Iron
Acids

Keywords

  • Antioxidants
  • Dipyridamole
  • HIV-1
  • Iron
  • Monocytes
  • Reactive oxygen species
  • U937 cells
  • gp120

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Virology

Cite this

Antioxidants and dipyridamole inhibit HIV-1 gp120-induced free radical-based oxidative damage to human monocytoid cells. / Foga, Irene O.; Nath, Avindra; Hasinoff, Brian B.; Geiger, Jonathan D.

In: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, Vol. 16, No. 4, 01.12.1997, p. 223-229.

Research output: Contribution to journalArticle

@article{b503df8811a94e7eb3763fe132ec32fb,
title = "Antioxidants and dipyridamole inhibit HIV-1 gp120-induced free radical-based oxidative damage to human monocytoid cells",
abstract = "Reactive oxygen species (ROS) may play an important role in HIV-1 pathogenesis and HIV-1 gp120-induced neurotoxicity. Our studies determined the extent to which gp120 increased ROS production in human monocytic U937 cells and the effectiveness of various agents, including dipyridamole (DPR), in blocking these responses. The thiobarbituric acid-reactive substances (TBARS) assay was used as a measure of recombinant gp120 (HIV-13B)-induced oxidative damage to U937 cells. As a control, TBARS production was measured using a hypoxanthine/xanthine superoxide generating system. There was gp120-induced oxidative damage in U937 cells with a concentration that produces 50{\%} of maximal effect (apparent EC50 value) of 11 pM. Polyclonal antiserum to gp120 significantly (p < 0.05) inhibited gp120-induced oxidative damage. gp120-induced oxidative damage was significantly inhibited 81{\%} (p < 0.01) by catalase/superoxide dismutase, 53{\%} (p < 0.05) by (±)-α-tocopherol, 78{\%} (p < 0.01) by desferrioxamine, and 82{\%} (p < 0.01) by ethylene diamine tetraacetic acid (EDTA). These results indicate that gp120 is capable of promoting iron-based oxygen free radical damage to U937 cells. DPR potently (p < 0.05) inhibited both hypoxanthine/xanthine- and gp120-induced oxidative damage with concentrations that produce 50{\%} inhibition (apparent IC50 values) of 1.3 μM for hypoxanthine/xanthine and 1.0 μM for gp120. Therapeutic intervention against ROS production may prevent HIV-1 neurotoxicity.",
keywords = "Antioxidants, Dipyridamole, HIV-1, Iron, Monocytes, Reactive oxygen species, U937 cells, gp120",
author = "Foga, {Irene O.} and Avindra Nath and Hasinoff, {Brian B.} and Geiger, {Jonathan D.}",
year = "1997",
month = "12",
day = "1",
doi = "10.1097/00042560-199712010-00001",
language = "English (US)",
volume = "16",
pages = "223--229",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Antioxidants and dipyridamole inhibit HIV-1 gp120-induced free radical-based oxidative damage to human monocytoid cells

AU - Foga, Irene O.

AU - Nath, Avindra

AU - Hasinoff, Brian B.

AU - Geiger, Jonathan D.

PY - 1997/12/1

Y1 - 1997/12/1

N2 - Reactive oxygen species (ROS) may play an important role in HIV-1 pathogenesis and HIV-1 gp120-induced neurotoxicity. Our studies determined the extent to which gp120 increased ROS production in human monocytic U937 cells and the effectiveness of various agents, including dipyridamole (DPR), in blocking these responses. The thiobarbituric acid-reactive substances (TBARS) assay was used as a measure of recombinant gp120 (HIV-13B)-induced oxidative damage to U937 cells. As a control, TBARS production was measured using a hypoxanthine/xanthine superoxide generating system. There was gp120-induced oxidative damage in U937 cells with a concentration that produces 50% of maximal effect (apparent EC50 value) of 11 pM. Polyclonal antiserum to gp120 significantly (p < 0.05) inhibited gp120-induced oxidative damage. gp120-induced oxidative damage was significantly inhibited 81% (p < 0.01) by catalase/superoxide dismutase, 53% (p < 0.05) by (±)-α-tocopherol, 78% (p < 0.01) by desferrioxamine, and 82% (p < 0.01) by ethylene diamine tetraacetic acid (EDTA). These results indicate that gp120 is capable of promoting iron-based oxygen free radical damage to U937 cells. DPR potently (p < 0.05) inhibited both hypoxanthine/xanthine- and gp120-induced oxidative damage with concentrations that produce 50% inhibition (apparent IC50 values) of 1.3 μM for hypoxanthine/xanthine and 1.0 μM for gp120. Therapeutic intervention against ROS production may prevent HIV-1 neurotoxicity.

AB - Reactive oxygen species (ROS) may play an important role in HIV-1 pathogenesis and HIV-1 gp120-induced neurotoxicity. Our studies determined the extent to which gp120 increased ROS production in human monocytic U937 cells and the effectiveness of various agents, including dipyridamole (DPR), in blocking these responses. The thiobarbituric acid-reactive substances (TBARS) assay was used as a measure of recombinant gp120 (HIV-13B)-induced oxidative damage to U937 cells. As a control, TBARS production was measured using a hypoxanthine/xanthine superoxide generating system. There was gp120-induced oxidative damage in U937 cells with a concentration that produces 50% of maximal effect (apparent EC50 value) of 11 pM. Polyclonal antiserum to gp120 significantly (p < 0.05) inhibited gp120-induced oxidative damage. gp120-induced oxidative damage was significantly inhibited 81% (p < 0.01) by catalase/superoxide dismutase, 53% (p < 0.05) by (±)-α-tocopherol, 78% (p < 0.01) by desferrioxamine, and 82% (p < 0.01) by ethylene diamine tetraacetic acid (EDTA). These results indicate that gp120 is capable of promoting iron-based oxygen free radical damage to U937 cells. DPR potently (p < 0.05) inhibited both hypoxanthine/xanthine- and gp120-induced oxidative damage with concentrations that produce 50% inhibition (apparent IC50 values) of 1.3 μM for hypoxanthine/xanthine and 1.0 μM for gp120. Therapeutic intervention against ROS production may prevent HIV-1 neurotoxicity.

KW - Antioxidants

KW - Dipyridamole

KW - HIV-1

KW - Iron

KW - Monocytes

KW - Reactive oxygen species

KW - U937 cells

KW - gp120

UR - http://www.scopus.com/inward/record.url?scp=0030731799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030731799&partnerID=8YFLogxK

U2 - 10.1097/00042560-199712010-00001

DO - 10.1097/00042560-199712010-00001

M3 - Article

C2 - 9402067

AN - SCOPUS:0030731799

VL - 16

SP - 223

EP - 229

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 4

ER -